Notable Series A funding efforts for new-to-the-scene biotechs with early phase assets include $410 million for Verdiva Bio in 2025 and $400 million for Kailera Therapeutics in late 2024
Biological effects of human exposure to environmental cadmium
Pediatric (FDA) Other brands Nephplex Rx, Nephrocaps, Reno Caps, Dotremin,
Do not overthink the timing
Retatrutide is not yet commercially available
Encapsulation of DDA-GSH-AuNCs into PLGA nanoparticles using the emulsion-evaporation method PLGA (30 mg) was dissolved in chloroform containing DDA-GSH-AuNCs (1.5 mL), and then emulsified into aqueous PVA solution (2.5% w/w, 5.0 mL) using sonication for 60 s (ultra-probe sonicator at 50 W, UP200Ht, Hielscher Ultrasonics, Teltow, Germany)